Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 1489 results

Clinical Trials / Apr 21, 2026

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
Clinical Trials / Apr 13, 2026

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)
Clinical Trials / Apr 02, 2026

A 24-week rPMS Study in Real-world Setting for Enerzair
Clinical Trials / Apr 07, 2026

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Clinical Trials / May 22, 2026

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
Clinical Trials / Aug 11, 2025

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Clinical Trials / Apr 20, 2026

Study of Out of Specification for Tisagenlecleucel
Clinical Trials / May 16, 2024

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Clinical Trials / Jan 14, 2025

Regulatory Post-Marketing Surveillance Study for Brolucizumab
Press release / Jul 21, 2015

Novartis erzielt im zweiten Quartal eine solide Performance mit starken Innovationen und Fortschritten bei Neueinführungen

Die fortzuführenden Geschäftsbereiche[2] steigern im zweiten Quartal den Umsatz, das operative Kernergebnis[1] und den Kerngewinn pro Aktie (kWk[1]): Der Nettoumsatz beläuft sich auf USD 12,7…

‹ Previous page
1
…
56
57
58
59
60
61
62
…
149
› Next page